Synthesis of <i>N</i>-Fused Polycyclic Indoles via Ligand-Free Palladium-Catalyzed Annulation/Acyl Migration Reaction
作者:Zhan Dong、Xiao-Wen Zhang、Weishuang Li、Zi-Meng Li、Wen-Yan Wang、Yan Zhang、Wei Liu、Wen-Bo Liu
DOI:10.1021/acs.orglett.8b04128
日期:2019.2.15
An efficient synthesis of N-fused polycyclic indoles by a palladium-catalyzed annulation/acylmigration cascade reaction is described. The reaction is ligand-free, scalable, and provides access to a diverse range of useful indole scaffolds from readily available starting materials. Supporting mechanistic studies indicate that the reaction likely proceeds via an intramolecular α-arylation mechanism
ARYL AND ARYLALKYL SUBSTITUTED PYRAZOLYL AND PYRIMIDINYL TRICYCLIC ENONES AS ANTIOXIDANT INFLAMMATION MODULATORS
申请人:AbbVie Inc.
公开号:US20150225397A1
公开(公告)日:2015-08-13
The present application relates to: (a) compounds of Formula (I):
and salts thereof, wherein R
1
, R
2
, R
3
, R
4
, R
5
, R
6
, m, n, X and Y are as defined in the specification; (b) compositions comprising such compounds and salts; and (c) methods of use of such compounds, salts, and compositions, particularly use for the treatment and prevention of diseases such as those associated with oxidative stress and inflammation.
primary amine catalyzed efficient and practical protocol for the large-scale synthesis of Wieland–Miescher and Hajos–Parrishketones as well as their analogues. This article describes a simple chiral primary amine catalyzed efficient and practical protocol for the large-scale synthesis of Wieland–Miescher and Hajos–Parrishketones as well as their analogues.
[EN] 2,6,7,8 SUBSTITUTED PURINES AS HDM2 INHIBITORS<br/>[FR] PURINES 2,6,7,8-SUBSTITUÉES UTILISÉES EN TANT QU'INHIBITEURS DE HDM2
申请人:MERCK SHARP & DOHME
公开号:WO2014120748A1
公开(公告)日:2014-08-07
The present invention provides 2,6,7,8 Substituted Purines as described herein or a pharmaceutically acceptable salt thereof. The representative compounds are useful as inhibitors of the HDM2 protein. Also disclosed are pharmaceutical compositions comprising the above compounds and potential methods of treating cancer using the same.
[EN] ARYL AND ARYLALKYL SUBSTITUTED PYRAZOLYL AND PYRIMIDINYL TRICYCLIC ENONES AS ANTIOXIDANT INFLAMMATION MODULATORS<br/>[FR] PYRAZOLYLE SUBSTITUÉ PAR UN ARYLE ET ARYLALKYLE ET PYRIMIDINYL ÉNONES TRICYCLIQUES COMME MODULATEURS ANTIOXYDANTS DE L'INFLAMMATION
申请人:ABBVIE INC
公开号:WO2015112792A1
公开(公告)日:2015-07-30
The present application relates to: (a) compounds of Formula (I): and salts thereof, wherein R1, R2, R3, R4, R5, R6, m, n, X and Y are as defined in the specification; (b) compositions comprising such compounds and salts; and (c) methods of use of such compounds, salts, and compositions, particularly use for the treatment and prevention of diseases such as those associated with oxidative stress and inflammation.